These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16278681)

  • 21. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
    Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
    Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B.
    Vadlamudi RK; Barnes CJ; Rayala S; Li F; Balasenthil S; Marcus S; Goodson HV; Sahin AA; Kumar R
    Mol Cell Biol; 2005 May; 25(9):3726-36. PubMed ID: 15831477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
    Min G
    Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
    Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
    Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
    Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.
    Gururaj AE; Rayala SK; Vadlamudi RK; Kumar R
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1001s-1007s. PubMed ID: 16467116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis.
    Kim SH; Lee HW; Kim YH; Koo YH; Chae HD; Kim CH; Lee PR; Kang BM
    Hum Reprod; 2009 May; 24(5):1133-41. PubMed ID: 19168872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of RELT homologues that associate with RELT and are phosphorylated by OSR1.
    Cusick JK; Xu LG; Bin LH; Han KJ; Shu HB
    Biochem Biophys Res Commun; 2006 Feb; 340(2):535-43. PubMed ID: 16389068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An essential role of Pak1 phosphorylation of SHARP in Notch signaling.
    Vadlamudi RK; Manavathi B; Singh RR; Nguyen D; Li F; Kumar R
    Oncogene; 2005 Jun; 24(28):4591-6. PubMed ID: 15824732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.
    Talukder AH; Li DQ; Manavathi B; Kumar R
    Oncogene; 2008 Sep; 27(39):5233-42. PubMed ID: 18521086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1.
    Meng Q; Rayala SK; Gururaj AE; Talukder AH; O'Malley BW; Kumar R
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5866-71. PubMed ID: 17389360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C-terminal kinase domain of the p34cdc2-related PITSLRE protein kinase (p110C) associates with p21-activated kinase 1 and inhibits its activity during anoikis.
    Chen S; Yin X; Zhu X; Yan J; Ji S; Chen C; Cai M; Zhang S; Zong H; Hu Y; Yuan Z; Shen Z; Gu J
    J Biol Chem; 2003 May; 278(22):20029-36. PubMed ID: 12624090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear localization and chromatin targets of p21-activated kinase 1.
    Singh RR; Song C; Yang Z; Kumar R
    J Biol Chem; 2005 May; 280(18):18130-7. PubMed ID: 15749698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LIM domain: from the cytoskeleton to the nucleus.
    Kadrmas JL; Beckerle MC
    Nat Rev Mol Cell Biol; 2004 Nov; 5(11):920-31. PubMed ID: 15520811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423.
    Hashimoto H; Sudo T; Maruta H; Nishimura R
    Drug Discov Ther; 2010 Feb; 4(1):1-4. PubMed ID: 22491145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.
    Karpov AS; Amiri P; Bellamacina C; Bellance MH; Breitenstein W; Daniel D; Denay R; Fabbro D; Fernandez C; Galuba I; Guerro-Lagasse S; Gutmann S; Hinh L; Jahnke W; Klopp J; Lai A; Lindvall MK; Ma S; Möbitz H; Pecchi S; Rummel G; Shoemaker K; Trappe J; Voliva C; Cowan-Jacob SW; Marzinzik AL
    ACS Med Chem Lett; 2015 Jul; 6(7):776-81. PubMed ID: 26191365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Untangling the complexity of PAK1 dynamics: The future challenge.
    Parrini MC
    Cell Logist; 2012 Apr; 2(2):78-83. PubMed ID: 23125950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety.
    Ndubaku CO; Crawford JJ; Drobnick J; Aliagas I; Campbell D; Dong P; Dornan LM; Duron S; Epler J; Gazzard L; Heise CE; Hoeflich KP; Jakubiak D; La H; Lee W; Lin B; Lyssikatos JP; Maksimoska J; Marmorstein R; Murray LJ; O'Brien T; Oh A; Ramaswamy S; Wang W; Zhao X; Zhong Y; Blackwood E; Rudolph J
    ACS Med Chem Lett; 2015 Dec; 6(12):1241-6. PubMed ID: 26713112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pak1: steps towards understanding the regulatory mechanisms of pacemaker function of the heart.
    Lei M; Ke Y; Solaro RJ
    Future Cardiol; 2007 Sep; 3(5):473-6. PubMed ID: 19804297
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
    Hao C; Wang L; Peng S; Cao M; Li H; Hu J; Huang X; Liu W; Zhang H; Wu S; Pataer A; Heymach JV; Eterovic AK; Zhang Q; Shaw KR; Chen K; Futreal A; Wang M; Hofstetter W; Mehran R; Rice D; Roth JA; Sepesi B; Swisher SG; Vaporciyan A; Walsh GL; Johnson FM; Fang B
    Cancer Lett; 2015 Feb; 357(1):179-185. PubMed ID: 25444907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.